The intestine is a unique immune environment that must respond to infectious organisms but remain tolerant to commensal microbes and food antigens. However, the molecular mechanisms that regulate immune cell function in the intestine remain unclear. Here we identify the POK/ZBTB family transcription factor Hypermethylated in cancer 1 (HIC1, ZBTB29) as a central component of immunity and inflammation in the intestine. HIC1 is specifically expressed in immune cells in the intestinal lamina propria (LP) in the steady state and mice with a T cell-specific deletion of HIC1 have reduced numbers of T cells in the LP. HIC1 expression is regulated by the Vitamin A metabolite retinoic acid, as mice raised on a Vitamin A-deficient diet lack HIC1-positive cells in the intestine. HIC1deficient T cells overproduce IL-17A in vitro and in vivo, and fail to induce intestinal inflammation, identifying a critical role for HIC1 in the regulation of T cell function in the intestinal microenvironment under both homeostatic and inflammatory conditions. Burrows et al. 3
INTRODUCTION
The intestinal immune system is constantly interacting with non-pathogenic commensal organisms and innocuous food antigens that must be tolerated immunologically, while maintaining the ability to rapidly respond to infectious organisms and toxins. To maintain this balance, unique immune cell populations are found in the intestinal microenvironment. For example, intestinal-resident dendritic cells (DCs) that express the surface marker CD103 have been shown affect intestinal homeostasis by producing the vitamin A metabolite retinoic acid (RA) (Scott, et al. 2011) . Intestinal macrophages have also been shown to play a central role in tolerance in the intestine (Smith, et al. 2010; Bain and Mowat, 2014) . Specific subsets of CD4 + T helper (T H ) cells, primarily FOXP3expressing regulatory T cells (T reg cells) and IL-17A-producing T H cells (T H 17 cells) are enriched in the intestinal lamina propria (LP) (Littman and Rudensky, 2010) , while CD8 + T cells and γδ T cells are found in the intraepithelial compartment (Cheroutre, et al. 2011) , acting in conjunction with IgA-producing B cells that are required to maintain tolerance to the commensal flora (Suzuki, et al., 2007) . However, the molecular mechanisms that regulate intestinal immune cell function in health and disease are not fully defined.
The POZ and Kruppel/Zinc Finger and BTB (POK/ZBTB) proteins are a family of transcription factors that play critical roles in a variety of biological processes such as gastrulation, limb formation, cell cycle progression, and gamete formation (Kelly and Daniel, 2006) . In the immune system, POK/ZBTB proteins are key regulators in cellular differentiation and function (Lee and Maeda, 2012) . For example, B-Cell CLL/Lymphoma 6 (BCL6, ZBTB27) is critical for the development of germinal centres Burrows et al. 4 (GCs) following immunization or infection. BCL6 is expressed at high levels in GC B cells (Allman et al., 1996) and T follicular helper (T FH ) cells (Nurieva et al., 2009 ) that together control the germinal centre response. Promyelocytic leukaemia zinc finger (PLZF, ZBTB16) is required for NKT cell development (Savage et al., 2008) and expression of PLZF has recently been shown to identify a multipotent progenitor of innate lymphoid cells (ILCs) (Constantinides et al., 2014) . T helper-inducing POZ/Kruppel-Like factor (ThPOK, ZBTB7B) is a master regulator of T H cell development in the thymus (Wang et al., 2008; Muroi et al., 2008) . Hypermethylated in cancer 1 (HIC1, ZBTB29) is a member of this family and has been shown to regulate proliferation and p53-dependent survival in a wide range of tumours. HIC1 is epigenetically silenced through DNA methylation in various human cancers (Chen et al., 2003; Wales et al., 1995) and it has been proposed that HIC1-depdent repression of SIRT1 was critical for the function of p53 (Chen et al., 2005) . However, the role of HIC1 in immune cells has not been examined.
In this study, we identify HIC1 as a regulator of intestinal immune responses under homeostatic and inflammatory conditions. We demonstrate that HIC1 is expressed in immune cells specifically in the intestinal lamina propria but not in other lymphoid or non-lymphoid tissues in the steady state. In the absence of HIC1 in T cells, we observe a significant reduction in the frequency of T cells in the LP and intraepithelial compartment, coincident with increased T H 17 cell responses. HIC1 expression in the LP is regulated by the vitamin A metabolite retinoic acid and under inflammatory conditions in the intestine, loss of HIC1 specifically in T cells renders mice resistant to the development of intestinal inflammation, suggesting that HIC1 is required for the Burrows et al. 5 pathogenicity of T cells in vivo. Thus, HIC1 plays a central role in intestinal immune homeostasis and inflammation. Burrows et al. 6 
RESULTS

HIC1 expression in immune cells is restricted to the intestine
To begin to address the role of HIC1 in the immune system, we examined the expression of HIC1 in CD45 + leukocytes in various tissues of mice with a fluorescent reporter gene inserted in the Hic1 locus (Hic1 Citrine mice) (Pospichalova et al., 2011) . Citrine expression in CD45 + cells was restricted to the intestine, with the only detectable Citrine-positive cells in the lamina propria and intraepithelial space ( Figure 1a ). Further characterization of the leukocytes in the LP revealed that a majority of T cell receptor β (TCRβ) chainexpressing CD4 + and CD8 + T cells and TCRγδ + CD8 + T cells in the LP expressed HIC1 ( Figure 1b ) and that TCRβ + CD8 + and TCRγδ + CD8 + intraepithelial lymphocytes (IELs) also expressed HIC1 (Figure 1c ). We also found that most MHCII + CD11c + CD64dendritic cells (DCs) and MHCII + CD64 + F4/80 + macrophages expressed HIC1 ( Figure   1 -figure supplement 1). However, HIC1 expression was not generalized for all lymphocytes in the LP, as B220 + B cells did not express HIC1 (Figure 1b ). Thus, HIC1 expression in immune cells specifically identifies intestinal resident populations.
T cell-intrinsic expression of HIC1 regulates intestinal immune homeostasis
As HIC1 was expressed in multiple immune cell populations in the LP, we next sought to determine the cell-intrinsic functions of HIC1 by focusing on its role specifically in T cells. To do this, we crossed mice with loxP sites flanking the Hic1 gene (Hic1 fl/fl mice) with mice that express the Cre recombinase under control of the Cd4 enhancer and promoter (Cd4-Cre mice) to generate mice with a T cell-intrinsic deletion of Hic1 (Hic1 ΔT mice). Hic1 ΔT mice displayed normal thymic development ( Thus, HIC1 expression is dispensable for peripheral T cell homeostasis. However, we found that the frequency and number of CD4 + and CD8 + TCRβ + cells in the LP (Figure   2a ,b) and CD8 + T cells in the intraepithelial compartment (Figure 2a ,c) was significantly reduced in the absence of HIC1, demonstrating that T cell-intrinsic expression of HIC1 is required for intestinal T cell homeostasis.
Lamina propria lymphocytes (LPLs) and intraepithelial lymphocytes (IELs)
display an activated, memory phenotype that includes the markers CD69 and CD103, cell surface molecules that are important for retention in the intestinal microenvironment.
CD69 has been shown to negatively regulate expression of sphingosine-1-phosphate receptor (S1PR1), which must be downregulated to establish tissue-residency (Matloubian et al., 2004; Skon et al., 2013) , while CD103 binds to the epithelial cellexpressed E-cadherin and is required for maintenance of intestinal T cells (Schön et al., 1999) . We found that HIC1-deficient CD4 + and CD8 + T cells in the LP and intraepithelial compartments expressed significantly reduced levels of CD69 and CD103 (Figure 2d ,e).
Strikingly, there was an almost complete loss of CD103 + CD69 + CD4 + T cells in the LP (Figure 2d ,e). Thus, the reduced frequency and number of CD4 + and CD8 + LPLs and IELs in Hic1 ΔT mice is associated with reduced expression of CD69 and CD103. Burrows et al. 8 
HIC1 is a negative regulator of IL-17A production by CD4 + T cells
In the intestinal LP, CD4 + T H 17 and T reg cells are found at higher frequencies than other T H cell subsets. Analysis of the CD4 + LPLs showed that although frequency of FOXP3 + T reg cells were equivalent between Hic1 fl/fl and Hic1 ΔT mice, the frequency of RORγt + IL-17A-expressing T H 17 cells in Hic1 ΔT mice was significantly increased (Figure 3a (Figure 3d ), resulting in a significant increase in the levels of secreted IL-17A ( Figure 3e ), which was also associated with increased Il17a expression in HIC1-deficient T H 17 cells ( Figure 3f ). Retroviral transduction of HIC1 into differentiating T H 17 cells resulted in a complete inhibition of IL-17A production (Figure 3g ,h). Taken together, these results suggest that HIC1 is a cell-intrinsic negative regulator of IL-17A production during T H 17 cell differentiation. Burrows et al. 9 The vitamin A metabolite RA plays a critical role in intestinal immune homeostasis (Brown and Noelle, 2015a) . Previous studies have shown that mice raised on a diet lacking vitamin A (Vitamin A-Deficient (VAD) diet) have defects in T H cell activation and intestinal migration, resulting in an overall impairment in T cell-driven immune responses in the intestine (Iwata et al., 2004; Johansson-Lindbom et al., 2005; Hall et al., 2011) . To test whether RA influenced HIC1 expression in intestinal T H cells, we raised Hic1 Citrine mice on a VAD diet. We found that LP T H cells from VAD mice failed to express HIC1 (Figure 4a ), suggesting that HIC1 expression in T H cells in the LP is dependent upon the presence of RA. Consistent with this, addition of RA to T H cells isolated from spleen or lymph nodes of mice activated in vitro with antibodies against CD3 and CD28 resulted in an upregulation of HIC1 at the mRNA and protein levels (Figure 4b, c) . Analysis of HIC1 expression using Hic1 Citrine mice further demonstrated that treatment of activated T H with RA led to increased HIC1 expression ( Figure 4d ).
Retinoic acid regulates expression of HIC1 in T cells in vitro and in vivo
Expression of HIC1 was dependent upon T H cell activation, as addition of RA to T H cells
in the absence of T cell receptor stimulation had no effect on the expression of Hic1 mRNA ( Figure 4e ). Thus, these results identify HIC1 as an RA-responsive gene in activated T H cells.
HIC1 is dispensable for expression of intestinal homing receptors
RA is critical for migration of immune cells to the intestine (Iwata et al., 2004) molecules, resulting in impaired intestinal migration. However, we failed to observe any reduction in expression of α4β7 and CCR9 on T H cells in the presence or absence of HIC1 following activation in the presence of RA ( Figure 5a ). Further, we found that T H cells isolated from the Peyer's patches or mLNs of Hic1 ΔT mice were not deficient in expression of CCR9 ( Figure 5-figure supplement 1) . These results demonstrate that other HIC1-dependent mechanisms such as reduced expression of CD69 and CD103 were responsible for the paucity of T H cells in the LP and that HIC1 is dispensable for RAdependent induction of intestinal homing molecules.
HIC1 is not required for inhibitory effects of RA on T H 17 cell differentiation
Several studies have demonstrated that RA can negatively affect the differentiation of T H 17 cells (Mucida et al., 2007; Hill et al., 2008; Schambach et al., 2007) although the precise mechanisms remain unclear. Based on our data showing heightened IL-17A production by HIC1-deficeint T H 17 cells in vitro and in vivo, we hypothesized that expression of HIC1 would be required for the RA-dependent reduction in T H 17 cell differentiation. In contrast to our expectations, addition of RA to either HIC1-sufficient or -deficient T H cells led to a significant reduction in the expression of IL-17A ( Figure   5b ). Thus, although HIC1 is upregulated by RA in T H cells and Hic1-deficient T H 17 cells express increased levels of IL-17A in vitro and in vivo, HIC1 dispensable for RAdependent regulation of T H 17 cell responses in vitro.
HIC1 regulates T cell-mediated inflammation in the intestine
We next examined whether dysregulated T H cell responses observed in naive Hic1 ΔT mice Burrows et al. 11 had any effect on the development of intestinal inflammation. Despite the reduced numbers of T H cells in the LP of Hic1 ΔT mice and the dysregulated production of IL-17A by Hic1-deficient T H 17 cells, we failed to observe any significant differences in intestinal architecture between naïve Hic1 fl/fl or Hic1 ΔT mice (Figure 6a , left panels). After induction of intestinal inflammation with intraperitoneal injection of a monoclonal antibody against CD3 (Rutz et al., 2015; Esplugues et al., 2011; Merger et al., 2002) , Thus, T cell-intrinsic expression of HIC1 modulates inflammation in the intestine, potentially by negatively regulating IL-17A production.
To directly assess the cell-intrinsic role of HIC1 in intestinal inflammation, we employed a T cell transfer model of intestinal inflammation (Powrie et al., 1993) . We adoptively transferred naïve CD4 + CD25 -CD45RB high T cells isolated from either Figure   7d ). Furthermore, consistent with our results under homeostatic conditions as well as following α-CD3 treatment, we found that the absence of HIC1 in T cells resulted in heightened production of IL-17A with no significant effect on the frequency of IFN-γpositive cells (Figure 7e ). Thus, HIC1 expression in T cells is critically required for the development of intestinal inflammation, possibly by limiting expression of IL-17A.
HIC1 is required to limit STAT3 signaling in T H 17 cells
In addition to directly repressing target genes, HIC1 has been shown to negatively regulate gene expression by several mechanisms including the recruitment of corepressors such as the CtBP, NuRD and polycomb repressive complex 2 (PRC2) complexes to target genes to mediate gene repression (Van Rechem et al., 2010; Boulay et al., 2012) . Further, HIC1 has also been shown to indirectly repress transcription by binding to transcriptional activators and preventing binding to target genes. HIC1 has been shown to interact with and inhibit DNA binding of transcription factors such as T cell factor-4 (TCF4), β-Catenin and STAT3 (Valenta et al., 2006; Lin et al., 2013; Hu et al., 2016) . As HIC1-deficient T H 17 cells produce heightened levels of the STAT3 target gene IL-17A (Durant et al., 2010) , we hypothesized that increased STAT3 activity was associated with HIC1 deficiency. We first examined the levels of IL-6-induced active phosphorylated STAT3 (pSTAT3) in HIC1-sufficient and -deficient T H 17 cells by flow cytometry. We found that loss of HIC1 had no effect on the frequency of pSTAT3positive T H cells (Figure 8a ), suggesting that HIC1 did not affect upstream STAT3 
Discussion
We have identified the transcriptional factor HIC1 as a novel regulator of intestinal immune homeostasis. In the steady state, HIC1 is specifically expressed in immune cells of the intestinal LP and intraepithelial niches in an RA-dependent manner, and mice with a T cell-intrinsic deletion of HIC1 have a dramatic decrease in the number of T cells in intestinal tissues. HIC1 deficiency leads to increased expression of IL-17A, possibly through the loss of STAT3 inhibition. Under inflammatory conditions, HIC1 expression in T cells is required for intestinal pathology, identifying HIC1 as a potential therapeutic target to treat intestinal inflammation.
Our results suggest that the micronutrient RA regulates HIC1 expression in immune cells in the intestine. In support of this, two unrelated genome-wide expression screens for genes in T H cells regulated by RA signaling have identified HIC1 as an RA/RARα-dependent gene, although no functional analyses were carried out (Kang et al., 2011; Brown et al., 2015b) . These results are consistent with an in silico study showing that the Hic1 gene contains multiple RA receptor response elements (RAREs) (Lalevée et al., 2011) . However, HIC1 is dispensable for RA-mediated expression of intestinal homing molecules and RA-dependent suppression of IL-17A production in vitro, suggesting that the RA-HIC1 axis plays a specific role in regulating intestinal T cell homeostasis that remains to be defined.
T cell-intrinsic deletion of HIC1 resulted in a significant reduction in the frequency and number of T cells in the intestinal microenvironment. Interestingly, mice raised on a VAD diet also display reduced numbers of intestinal T cells (Iwata et al., 2004) . As RA has been shown to regulate expression of intestinal homing molecules such Burrows et al. 15 as CCR9 and α4β7 integrin, we first suspected that defective trafficking to the intestine was responsible for the paucity of T cells in the intestines of Hic1 ΔT mice; however, we did not observe any defects in the ability of Hic1-deficient T cells to express CCR9 or α4β7. In addition, we observed a significant influx of T cells into intestinal tissues upon induction of inflammation, further suggesting that migration to the intestine is not regulated by expression of HIC1. However, we did observe that the Hic1-deficient T cells present in the intestine at steady state expressed significantly lower levels of the surface molecules CD69 and CD103. These molecules are expressed by tissue-resident cells and are required for retention in tissues. Indeed, similar to our results, CD103-deficient mice have a severe reduction in the number of T cells in the intestine (Schön et al., 1999) .
Thus, HIC1 appears to be required for the optimal expression of CD69 and CD103 and retention of T cells in the intestinal microenvironment.
In addition, CD69 and CD103 are characteristic markers of a subset of memory T cells known as tissue resident memory T (T RM ) cells. T RM cells are long-lived quiescent cells that are thought to have derived from effector T cells that have migrated into nonlymphoid tissues. Interestingly, HIC1 has been shown to control fundamental cellular processes such as cell growth and survival (Rood and Leprince, 2013; Dehennaut et al., 2012) . HIC1 has been shown to interact with and regulate key transcription factors involved in cell cycle progression and cellular metabolism (Van Rechem et al., 2010; Li et al., 2012) . For example, HIC1 is involved in a regulatory feed back loop with the deacteylase SIRT1 (Chen et al., 2005) , which is a key regulator of fatty acid oxidation (Gerhart-Hines et al., 2007) . Further, it has been demonstrated that fatty acid metabolism is key to memory T cell development and survival (van der Windt and Pearce, 2012; Burrows et al. 16 Pearce et al., 2009 ). Thus, it is possible that in addition to directly regulating T cell retention in tissues, HIC1 may also be required in T cells to promote quiescence through metabolic pathways. Future studies will aim to characterize the role for HIC1 in T cell quiescence and memory development.
Another observation was the increase in the frequency of IL-17A-producing T H 17 cells in the intestine of Hic1 ΔT mice. T H 17 cells have been shown to play an important role in host defense to extracellular bacteria and fungi (Annunziato et al., 2015) .
However, they have also been described as pathogenic in multiple inflammatory diseases such as psoriasis and rheumatoid arthritis, and targeting IL-17A has proven to be an effective therapy (Papp et al., 2012; Leonardi et al., 2012; Genovese et al., 2010) .
However, the role of IL-17A in inflammatory bowel disease is controversial. Initial studies using the T cell transfer model of colitis provided the first evidence that IL-23driven T H 17 cells were pathogenic (Ahern et al., 2010) . However, targeted therapies against IL-17A in Crohn's disease have been proven ineffective (Targan et al., 2012; Hueber et al., 2012) and recent studies have shown that IL-17A is important for maintaining intestinal barrier integrity and has a protective role in regard to the development of colitis (Lee et al., 2015; Maxwell et al., 2015) . Further, it is becoming more apparent that the T H 17 cell lineage has a degree of heterogeneity with regards to pathogenicity. For example, T H 17 cells differentiated in the presence of TGFβ are less pathogenic and produce higher levels of IL-10 while cells differentiated in the presence of IL-23 are more pathogenic and can produce IFN-γ (Lee et al., 2012; McGeachy et al., 2007) . In addition, T H 17 cells have a degree of plasticity and fate-mapping studies have shown that 'ex-T H 17' cells lose their ability to produce IL-17A altogether and exclusively Burrows et al. 17 produce IFN-γ under certain conditions (Hirota et al., 2011) . As our studies show increased production of IL-17A from T H 17 cells and a lack of pathogenicity in multiple mouse models of intestinal inflammation, we hypothesize that in the absence of HIC1, T H 17 cells are skewed to a more protective lineage and do not transition into pathogenic cells. The precise molecular mechanisms of how HIC1 regulates the pathogenicity of T cells remains to be fully elucidated.
In summary, we have identified the transcriptional factor HIC1 as an RAresponsive cell-intrinsic regulator of T cell function in the intestine. Through its interaction with STAT3, HIC1 limits IL-17A production by T H 17 cells and is required for the development of intestinal inflammation. Together, these results suggest that HIC1 is an attractive therapeutic target for the treatment of inflammatory diseases of the intestine such as Crohn's disease and potentially other diseases associated with dysregulated T H 17 cell responses.
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METHODS
Ethics statement
Experiments were approved by the University of British Columbia Animal Care Committee (Protocol number A15-0196) and were in accordance with the Canadian Guidelines for Animal Research.
Mice
The generation of Hic1 Citrine mice has been described (Pospichalova et al., 2011) and the generation of Hic1 fl/fl mice will be described elsewhere (manuscript in preparation). Cd4-Cre mice were obtained from Taconic. Animals were maintained in a specific pathogenfree environment at the Biomedical Research Centre animal facility.
Diet Studies
Vitamin A-deficient (TD.09838) diet was purchased from Harlan Teklad Diets. At day 14.5 of gestation, pregnant females were administered the vitamin A-deficient diet and maintained on diet until weaning of litter. Upon weaning, females were returned to standard chow, whereas weanlings were maintained on special diet until use.
Antibodies and flow cytometry
Absolute numbers of cells were determined via hemocytometer or with latex beads for LP samples. Intracellular cytokine (IC) staining was performed by stimulating cells with phorbol 12-myristate 13-acetate (PMA), ionomycin, and Brefeldin-A (Sigma) for 4 hours and fixing/permeabilizing cells using the eBioscience IC buffer kit. All antibody dilutions Burrows et al. 19 and cell staining were done with PBS containing 2% FCS, 1 mM EDTA, and 0.05% sodium azide. Fixable Viability Dye eFluor 506 was purchased from eBioscience to exclude dead cells from analyses. Prior to staining, samples were Fc-blocked with buffer containing anti-CD16/32 (93, eBioscience) and 1% rat serum to prevent non-specific antibody binding. Cells were stained with fluorescent conjugated anti-CD11b (M1/70; in house), anti-CD4 (GK1.5), anti-CD8 (53-6.7), anti-TCRβ (H57-597 
RNA isolation and quantitative real-time PCR
Tissues were mechanically homogenized and RNA was extracted using the TRIzol method according to the manufacturer's instructions (Ambion). cDNA was generated using High Capacity cDNA reverse transcription kits (Applied Biosystems). Quantitative 
Cell Culture
CD4 + T cells were isolated from spleen and LNs by negative selection using an EasySep
Mouse CD4 + T cell isolation kit (StemCell Technologies). 5 x 10 5 CD4 + cells were cultured for up to 5 days in DMEM supplemented with 10% heat-inactivated FBS, 2 mM Burrows et al. 21 glutamine, 100 U/ml penicillin, 100 µg/ml streptomycin, 25 mM HEPES, and 5 x 10 -5 2-ME with 1 µg/ml plate bound anti-CD3 (145-2C11) and anti-CD28 (37.51). CD4 + T cells were polarized under T H 17 cell-(20 ng/ml IL-6, 10 ng/ml IL-23, TNF-α, IL-1β, 1 ng/ml TGF-β1, 10 µg/ml anti-IFN-γ and anti-IL-4), T H 1 cell-(10 ng/ml IL-2, IL-12 and 5 µg/ml anti-IL-4), T H 2 cell-(10 ng/ml IL-2, IL-4 and 5 µg/ml anti-IFN-γ) or iT reg cell-(10 ng/ml IL-2 and TGFβ1) promoting conditions. In some cases, cells were plated as above in the presence of 10 nM Retinoic Acid (Sigma-Aldrich).
ELISA IL-17A production was analyzed from supernatants taken on day 4 of CD4 + T cell in vitro culture using commercially available antibody pairs (eBioscience).
Anti-CD3-induced intestinal inflammation
Mice were administered 30 µg of anti-CD3ε antibody (145-2C11) in 400µl PBS by intraperitoneal injection. Animals were monitored daily after injection and euthanized at 48 hours post injection. At endpoint, sections of the distal ileum were fixed in 10% buffered formalin, embedded in paraffin and stained with H&E. Histological inflammation were blindly scored on a scale of 0 to 4, where 0 represented a normal ileum and 4 represented severe inflammation. Specific aspects such as infiltrating immune cells, crypt length, epithelial erosion, and muscle thickness were taken into account. Burrows et al. 22 CD4 + cells were enriched from spleens and peripheral LNs (pLNs) of Hic1 fl/fl or Hic1 ΔT mice with an EasySep Mouse CD4 + T cell isolation kit (StemCell Technologies) and stained with anti-CD4, anti-CD25 and anti-CD45RB. Naive CD4 + CD25 -CD45RB hi cells were purified by cell sorting. CD4 + CD25 -CD45RB hi naive T cells (4 × 10 5 ) were injected intraperitoneally into age-and sex-matched Rag1 -/mice, which were monitored for weight loss and sacrificed 6 weeks after initiation of the experiment. At endpoint, proximal colon was fixed, embedded, and stained with H&E. Histological inflammation was scored as above.
T cell Transfer Colitis
Isolation of Intraepithelial and Lamina Propria Leukocytes
Peyer's patches were removed from the small intestine, which was cut open longitudinally, briefly washed with ice-cold PBS and cut into 1.5 cm pieces. Tissue was incubated in 2mM EDTA PBS for 15 minutes at 37°C and extensively vortexed.
Supernatants were collected and pelleted then re-suspended in 30% Percoll solution and centrifuged for 10 minutes at 1200 rpm. The pellet was collected and used as intraepithelial leukocytes. Remaining tissue was digested with Collagenase/Dispase (Roche) (0.5 mg/mL) on a shaker at 250 rpm, 37°C, for 60 minutes, extensively vortexed and filtered through a 70µm cell strainer. The flow-through cell suspension was centrifuged at 1500rpm for 5 min. The cell pellet was re-suspend in 30% Percoll solution and centrifuged for 10 minutes at 1200 rpm. The pellet was collected and used as lamina propria leukocytes. Burrows et al. 23 Cells were lysed and immunoprecipitation carried out using antibodies against STAT3 (C-20; Santa Cruz) and FLAG (M2; Sigma). Immunoblotting was carried out using antibodies against STAT3, HIC1 (H-123; Santa Cruz) and GAPDH (GA1R; in house).
Cell lysis, Immunoprecipitation and Immunoblotting
Chromatin Immunoprecipitiation
Naive CD4 + T cells were activated and T H 17 polarized for 3 days, followed by 
Retroviral Transduction
Platinum E cells were transiently transfected using the calcium phosphate method with MigR1 expression plasmids encoding GFP alone or FLAG-HIC1. Viral supernatants were collected after 48h, supplemented with 8 µg/ml polybrene (EMD Millipore) and added to T cells that had been activated under T H 17 cell-polarizing conditions for 48 h. T cells (2 x 10 6 ) were incubated in 24 well plates with 1 ml viral supernatants. After 24 hours, viral supernatant was replaced with conditioned culture medium and cells were Burrows et al. 24 cultured under T H 17 cell-polarizing conditions for an additional 3 days.
Statistics
Data are presented as mean ± S.E.M. Statistical significance was determined by a twotailed Student's t-test using GraphPad Prism 5 software. Results were considered statistically significant with P < 0.05. 
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